Register now for this free live demo Thursday, September 17 @ 1:00pm Eastern. See Aimee, Find-A-Code's AI medical coding expert.
You will be amazed at the coding questions she can answer for you. Here are some examples:
What modifiers are commonly used with this CPT code?
What chaned for this code in 2025?
Explain this CPT code in plain language.
How should I code chronic hear failure?
Is J44.1 part of any HCC's'?
What are the clinical indicators for acute kidney failure?
Why Find-A-Code?
NEW Aimee AI expert makes you a faster, better coder
Complete Code Sets: CPT®, ICD-10-CM, HCPCS and more
The Easiest, Fastest, and Most Accurate NCCI Validation
Complete NCD/LCD Policies
All The Features You Need
AHA Coding Clinic® integration
RVUs with facility factors
UCR fees by location
Commercial payer policies
Common Language Descriptions (CLDs)
Many, many more!
AHA Coding Clinic® for HCPCS - 2004 Quarter 2; FOR your INFORMATION
Pass-through payment for newly approved drugs and biologicals
The following drugs were designated eligible for pass-through payment under the OPPS by CMS, effective April 1, 2004. HCPCS Effective date for pass-through status SI APC Short descriptor Long descriptor Payment rate Minimum unadjusted copayment Effective date for payment rate C9124 4/1/2004 G 9124 Injection, daptomycin Injection, daptomycin, per 1 mg $0.31 $0.05 1/1/2004 C9125 4/1/2004 G 9125 Injection, risperidone Injection, risperidone, per 12.5 mg $131.86 $19.71 1/1/2004 J2783 4/1/2004 G 0738 Rasburicase Injection, rasburicase, 0.5 mg $105.54 $17.63 4/1/2004 These payments will be temporary until there is sufficient cost data...
Note: The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.
Article Overview
This premium article covers CMS outpatient payment updates for newly approved drugs and biologicals under the OPPS, including the effective dates for pass-through status and associated payment information. It is aimed at coding, billing, and reimbursement professionals who need to track Medicare outpatient drug payment changes and related HCPCS references.
Why This Topic Matters
These updates affect how outpatient drugs and biologicals are reported and reimbursed under Medicare. Knowing which CMS pass-through items are included and when payment status changes take effect helps revenue cycle and coding teams stay current.
What You Will Learn
How CMS described OPPS pass-through payment updates for newly approved drugs and biologicals
Which types of outpatient payment information are provided for the listed items
How effective dates and payment-related fields are presented in CMS guidance
Why temporary pass-through status matters for Medicare outpatient billing
Quick, Current, Complete - www.findacode.com